ArticleFrontiers in immunology2021

Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.

Katarzyna Pawlik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.